Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-heterocyclic sulfonamides having endothelin receptor activity

N-heterocyclic sulfonamides having endothelin receptor activity

US Patent 5668137 · Granted Sep 16, 1997

Estimated economic value: $1,365,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative dise2022
[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative dise2020
[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative dise2019
Chemical compounds2018
[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative dise2018
Chemical compounds2017
Chemical compounds2015
4-anilino quinazoline derivatives as antiproliferative agents2013
Chemical compounds—6432012
Bicyclic derivatives for use in the treatment of androgen receptor associated co2011
Compounds effecting glucokinase2011
4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB receptor tyrosine kinase2010